NCT01154634View on ClinicalTrials.gov

Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Reflux

Interventions

DRUG

AZD2516, 5 mg

Capsule, oral

DRUG

AZD2516, 16 mg

Capsule, oral

DRUG

AZD2516, 40 mg

Capsule, oral

DRUG

Placebo

Capsule, oral

Trial Locations (2)

Unknown

Research Site, Leuven

Research Site, Amsterdam

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY